A Molecular Map Reveals How Down Syndrome Alters Brain Development

Scientists at UCLA have created one of the first cellular-resolution molecular maps detailing how Down syndrome alters human brain development before birth, offering new insight into the prenatal origins of neurodevelopmental differences associated with the condition.

The study, published in Science, analyzed more than 100,000 nuclei from human prenatal neocortex samples collected across 26 pre-genotyped donors during gestational weeks 13 to 23. This period represents the only window during which all cortical neurons a person will carry for their entire life are generated.

By measuring both gene activity and chromatin accessibility in each cell, researchers identified molecular pathways and regulatory factors that may drive neurodevelopmental changes in Down syndrome. The findings reveal disruptions in the developmental sequence of neurogenesis, altering the timing and composition of neuron production in the developing brain.

Specifically, the study found increases in certain types of neurons, including intratelencephalic (IT) neurons and double-positive neurons, during mid-gestation. These shifts may help explain later differences in cognition, learning, and sensory processing observed in individuals with Down syndrome.

The molecular atlas also uncovered significant convergence between the disruptions identified in Down syndrome and genetic risk signatures associated with other neurodevelopmental and neuropsychiatric conditions, including autism, epilepsy, and developmental delay. This suggests that Down syndrome may provide a window into shared biological mechanisms underlying a broader range of conditions.

Researchers note that while the field has historically focused on the adult brain in Down syndrome and its link to Alzheimer’s disease, this study fills a critical gap by examining the prenatal period. Understanding early developmental changes could lay the groundwork for future therapeutic strategies aimed at supporting brain development from the earliest stages.

The resource resolves longstanding contradictions in the field by providing a detailed, cell-by-cell view of how the presence of an extra chromosome 21 alters the molecular landscape of the developing human neocortex. For the first time, scientists can systematically investigate what occurs in the developing brain of individuals with Down syndrome during this crucial phase of neurogenesis.